NASDAQ: DNTH · Health Care / Biotechnology: Pharmaceutical Preparations

Dianthus Therapeutics Inc.

How Dianthus Therapeutics Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap
$4.6B
Price
$82.70
P/E
-23.6
EPS (TTM)
$-3.51
1-year return
144.5%
Dividend yield
0.0%
52-week range
$40.39–$88.32

Compared with

For information only, not investment advice. Data may contain errors. Disclaimer · Sources